Form 15-12G CANTALOUPE, INC.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 001-33365
Cantaloupe, Inc.
(Exact name of registrant as specified in its charter)
1743 Maplelawn Drive
Troy, Michigan 48084
(888) 365-7382
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, no par value
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
☒ |
|
Rule 12g-4(a)(2)
|
☐ |
|
Rule 12h-3(b)(1)(i)
|
☒
|
|
Rule 12h-3(b)(1)(ii)
|
☐ |
|
Rule 15d-6
|
☐
|
|
Rule 15d-22(b)
|
☐ |
Approximate number of holders of record as of the certification or notice date: One (1).
Pursuant to the requirements of the Securities Exchange Act of 1934, Cantaloupe, Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
|
CANTALOUPE, INC.
|
|||
|
Date: May 18, 2026
|
By:
|
/s/ Brittany Westerman
|
|
|
Name:
|
Brittany Westerman
|
||
|
Title:
|
Vice President and Secretary
|
||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grey Wind Capital Partners with Maher Services and F. G. Sullivan to Build a Leading New England Water Well Services Platform
- Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
- Tanner Health and InStockRx Partner to Ensure Every Medication Dose Reaches a Patient in Need
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share